Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Study EV-103 cohort L: Evaluating perioperative enfortumab vedotin monotherapy in cis-ineligible muscle invasive bladder cancer (MIBC) (trial in progress).
Study EV-103 cohort L: Evaluating perioperative enfortumab vedotin monotherapy in cis-ineligible muscle invasive bladder cancer (MIBC) (trial in progress). Hoimes, C. J., Flaig, T. W., Srinivas, S., Mar, N., Petrylak, D. P., O'Donnell, P. H., Bilen, M., Sasse, C., Yu, Y., Birrenkott, M., Rosenberg, J. E. LIPPINCOTT WILLIAMS & WILKINS. 2022View details for DOI 10.1200/JCO.2022.40.6_suppl.TPS587
View details for Web of Science ID 000771008900593